Table 2.

Summary of clinical and pathological data, including age, sex, post-mortem interval (PMI), brain weight (in grams), classification for the study (control, early AD, or advanced AD), Braak stage (Braak and Braak 1991, Braak et al. 2006), CERAD score (Mirra et al. 1991), and clinical diagnosis (cause of death).

Case	Age (years)	Sex	Post-mortem interval (PMI)	Brain weight (g)	Classification	Braak stage	CERAD score	Clinical diagnosis (cause of death)
1	63	Male	19	1550	Control	No NT pathology	Absent (0)	Coronary artery disease; right tibial osteomyelitis
2	66	Female	14	1280	Control	No NT pathology	Absent (0)	Pancreatic carcinoma
3	74	Male	24.5	1219	Control	No NT pathology	Absent (0)	Glioblastoma
4	77	Male	16	1183	Control	No NT pathology	A	Coronary artery disease; atherosclerosis
5	63	Female	19	1209	Control	No NT pathology	Absent (0)	Abdominal metastatic carcinoma
6	86	Male	13	1349	Control	No NT pathology	A	Hydrocephalus → SDH after shunt
7	82	Female	13	1175	Early AD	Stage I	A	Metastatic adenocarcinoma (lung); respiratory insufficiency
8	91	Male	20	1364	Early AD	Stage I	B	Pneumonia; renal failure
9	72	Male	24	1200	Early AD	Stage I	C	Cardiac arrhythmia; mild cognitive impairment
10	68	Female	9	1074	Early AD	Stage I	B	Retroperitoneal tumor
11	70	Female	21	1249	Early AD	Stage I	B	Metastatic squamous cell carcinoma (lung)
12	77	Male	7	1080	Early AD	Stage II	B	Multiple myeloma
13	66	Female	2.5	900	Advanced AD	Stage V	C	Alzheimer’s disease; severe atherosclerosis; pneumonia
14	77	Male	9.2	1300	Advanced AD	Stage V	C	Alzheimer’s disease; hypertension; COPD
15	74	Female	12	1350	Advanced AD	Stage V	C	Alzheimer’s disease; melanoma
16	73	Male	8	1350	Advanced AD	Stage V	C	Alzheimer’s disease; atherosclerosis
17	77	Female	10	1093	Advanced AD	Stage V	C	Alzheimer’s disease; pneumonia
18	63	Male	48	1653	Advanced AD	Stage VI	C	Alzheimer’s disease; acute renal failure